Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Nankivell

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Lancet (London, England)|December 8, 2015
Primary chemotherapy versus primary surgery for ovarian cancer - Authors' replySean Kehoe, Matthew Nankivell
The Lancet. Oncology|December 7, 2017
Neoadjuvant chemotherapy in oesophageal adenocarcinoma - Authors' replyDerek Alderson, Matthew Nankivell, Ruth Langley, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 2, 2016
Primary Surgery or Neoadjuvant Chemotherapy in Advanced Ovarian Cancer: The Debate Continues…Alexandra Leary, Renee Cowan, Dennis Chi, et al.
Lancet (London, England)|April 14, 2017
Whole brain radiotherapy for non-small cell lung cancer - Authors' replyRuth E Langley, Matthew Nankivell, Rachael Barton, et al.
Statistics in Medicine|May 19, 2025
Sample Size Calculation in Dose Optimization Trials Using the Margin of Practical Non-InferiorityHakim-Moulay Dehbi, Sean Devlins, Alexia Iasonos, et al.
Thorax|November 25, 2010
The learning curve for EBUS-TBNANeal Navani, Matthew Nankivell, Parthiban Nadarajan, et al.
International Journal of Radiation Oncology, Biology, Physics|October 12, 2010
Induction chemotherapy and continuous hyperfractionated accelerated radiotherapy (chart) for patients with locally advanced inoperable non-small-cell lung cancer: the MRC INCH randomized trialMatthew Hatton, Matthew Nankivell, Ethan Lyn, et al.
European Journal of Cancer (Oxford, England : 1990)|August 4, 2020
Impact of sex and age on chemotherapy efficacy, toxicity and survival in localised oesophagogastric cancer: A pooled analysis of 3265 individual patient data from four large randomised trials (OE02, OE05, MAGIC and ST03)Avani Athauda, Matthew Nankivell, Ruth E Langley, et al.
Annals of Surgery|September 14, 2021
Prognostic Significance of Negative Lymph Node Long Axis in Esophageal Cancer: Results From the Randomized Controlled UK MRC OE02 TrialMaximilian Kloft, Jessica E Ruisch, Gayatri Raghuram, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 28, 2011
Endobronchial ultrasound-guided transbronchial needle aspiration for the diagnosis of intrathoracic lymphadenopathy in patients with extrathoracic malignancy: a multicenter studyNeal Navani, Matthew Nankivell, Ian Woolhouse, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Lancet (London, England)|December 8, 2015
Primary chemotherapy versus primary surgery for ovarian cancer - Authors' replySean Kehoe, Matthew Nankivell
The Lancet. Oncology|December 7, 2017
Neoadjuvant chemotherapy in oesophageal adenocarcinoma - Authors' replyDerek Alderson, Matthew Nankivell, Ruth Langley, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 2, 2016
Primary Surgery or Neoadjuvant Chemotherapy in Advanced Ovarian Cancer: The Debate Continues…Alexandra Leary, Renee Cowan, Dennis Chi, et al.
Lancet (London, England)|April 14, 2017
Whole brain radiotherapy for non-small cell lung cancer - Authors' replyRuth E Langley, Matthew Nankivell, Rachael Barton, et al.
Statistics in Medicine|May 19, 2025
Sample Size Calculation in Dose Optimization Trials Using the Margin of Practical Non-InferiorityHakim-Moulay Dehbi, Sean Devlins, Alexia Iasonos, et al.
Thorax|November 25, 2010
The learning curve for EBUS-TBNANeal Navani, Matthew Nankivell, Parthiban Nadarajan, et al.
International Journal of Radiation Oncology, Biology, Physics|October 12, 2010
Induction chemotherapy and continuous hyperfractionated accelerated radiotherapy (chart) for patients with locally advanced inoperable non-small-cell lung cancer: the MRC INCH randomized trialMatthew Hatton, Matthew Nankivell, Ethan Lyn, et al.
European Journal of Cancer (Oxford, England : 1990)|August 4, 2020
Impact of sex and age on chemotherapy efficacy, toxicity and survival in localised oesophagogastric cancer: A pooled analysis of 3265 individual patient data from four large randomised trials (OE02, OE05, MAGIC and ST03)Avani Athauda, Matthew Nankivell, Ruth E Langley, et al.
Annals of Surgery|September 14, 2021
Prognostic Significance of Negative Lymph Node Long Axis in Esophageal Cancer: Results From the Randomized Controlled UK MRC OE02 TrialMaximilian Kloft, Jessica E Ruisch, Gayatri Raghuram, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 28, 2011
Endobronchial ultrasound-guided transbronchial needle aspiration for the diagnosis of intrathoracic lymphadenopathy in patients with extrathoracic malignancy: a multicenter studyNeal Navani, Matthew Nankivell, Ian Woolhouse, et al.
Pageof 5